We are studying a new treatment using fat-derived cells for patients with autoimmune xerostomia. The goal is to see if it can improve symptoms and is safe to use.
Health conditions and diseases that the clinical trial is designed to study and treat.
Autoimmune Xerostomia is a condition where the body's immune system attacks the glands that produce saliva, leading to a persistent dry mouth, which can cause difficulty in swallowing, speaking, and an increased risk of dental issues.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.